Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

NCT00759720 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

447

Enrollment

INDUSTRY

Sponsor class

Stopped Potential hepatic safety signal

Conditions

Diabetes Mellitus

Interventions

DRUG: TAK-559 and glyburide
DRUG: TAK-559 and glyburide
DRUG: Glyburide

Sponsor

Takeda